Centrus Energy’s core business model is anchored in uranium enrichment services with a strong government partnership providing defensible backlog and funding. The company leverages its strategic position amid geopolitical supply constraints to maintain a differentiated market stance, though the und…
Centrus Energy (LEU) Q4 2025: $2.3B LEU Backlog and $900M HALEU Award Signal Industrial Build-Out Inflection
Centrus Energy’s 2025 results reflect a strategic pivot to domestic uranium enrichment capacity expansion, anchored by a $2.3 billion low-enriched uranium (LEU) backlog and a $900 million high-assay low-enriched uranium (HALEU) government contract. The company’s industrial build-out, including centrifuge manufacturing and facility upgrades, positions it to address tightening supply dynamics and national security demands. Execution risks remain, but the capital raise and government support underpin a transformative growth trajectory.
Summary
- Domestic Enrichment Expansion: Centrus is advancing a major industrial build-out to meet growing LEU and HALEU demand.
- Government Partnership Leverage: A $900 million DOE award and NNSA sole-source intent enhance funding and market positioning.
- Execution and Capital Deployment Focus: Operational scale-up and supply chain readiness are prioritized to meet milestone timelines.
Business Overview
Centrus Energy is a U.S.-based nuclear fuel supplier specializing in uranium enrichment services, primarily producing low-enriched uranium (LEU) used to fuel commercial nuclear reactors. The company operates two major segments: LEU enrichment, which contributes the majority of revenues, and Technical Solutions, which includes government contracts such as HALEU production and operations. Centrus generates revenue through long-term and contingent contracts for separative work units (SWU), uranium sales, and technical service contracts.
Performance Analysis
For the full year 2025, Centrus reported revenue of $448.7 million, a modest 1.5% increase over 2024, with net income rising to $77.8 million. The LEU segment maintained relatively flat revenue at $346.2 million despite a 54% decline in uranium sales, offset by a 21% increase in SWU revenue driven by a 23% volume increase. This volume growth reflects robust demand underpinned by a $2.3 billion contingent LEU backlog, signaling strong commercial pipeline visibility. The Technical Solutions segment grew 11% to $102.5 million, fueled by expanded HALEU operation contract revenues.
Gross profit improved 5% year-over-year to $117.5 million, with the LEU segment's gross margin rising 19%, driven by favorable SWU contract mix and volumes. However, Technical Solutions gross profit declined 66% due to increased costs on the HALEU contract, reflecting ongoing Phase 2 contract negotiations and undefinitized cost recoveries. Notably, a delayed Russian shipment in Q4 2025 deferred margin benefits into 2026, introducing some near-term margin pressure. Centrus ended 2025 with a strengthened balance sheet, holding approximately $2 billion in unrestricted cash, supporting its planned capital-intensive expansion.
- Backlog Strength: The $3.8 billion total backlog, including $2.9 billion LEU and $900 million Technical Solutions, extends to 2040, underpinning long-term revenue visibility.
- Margin Dynamics: LEU margin expansion offset by Technical Solutions cost pressures and shipment timing nuances.
- Capital Readiness: Significant capital raised via equity and convertible notes supports industrial build-out and supply chain investments.
Overall, Centrus’s financials demonstrate a business transitioning from legacy LEU operations toward a capital-intensive growth phase centered on domestic enrichment expansion and HALEU production, with strong government partnerships as a critical enabler.
Executive Commentary
"2025 was a milestone year for Centrus, marked by continuous improvements and the official launch of our centrifuge build-out. Our base case build-out will address our substantial LEU backlog and the DOE’s HALEU enrichment award, positioning us to meet both commercial and national security needs."
Amir Bexler, President and Chief Executive Officer
"Our strong execution in 2025, coupled with a $2 billion cash balance, allows us to fund the supply chain and facility investments necessary for the industrial build-out. We are confident in meeting our milestones and reaching end-of-a-kind costs for enrichment capacity."
Todd Tonelli, Chief Financial Officer
Strategic Positioning
1. Industrial Build-Out Anchored by Government Funding
Centrus’s $900 million DOE HALEU enrichment award, subject to negotiation, provides a cornerstone for its commercial-scale uranium enrichment expansion in Piketon, Ohio. This funding, combined with a potential increase to $1 billion, offers a low-cost capital source distinct from debt or equity, enabling the company to scale HALEU production capacity to 12 metric tons annually post-2030. The award also signals government confidence in Centrus as a strategic supplier for national security needs, reinforced by the NNSA’s intent to sole source enrichment activities.
2. Leveraging a $2.3 Billion LEU Backlog to Drive Capacity Expansion
The sizable contingent LEU backlog underpins Centrus’s near- and medium-term revenue visibility and justifies the ramp-up of domestic enrichment capacity. With $2.1 billion under definitive agreements, the backlog reflects strong customer commitments, although some contracts remain contingent on securing additional investment. Centrus aims to convert contingencies into firm contracts as it advances operational readiness and capital deployment.
3. Supply Chain and Operational Excellence as Execution Priorities
Operational execution is critical given the complexity of centrifuge manufacturing and facility expansion. Centrus has initiated supply chain readiness programs and partnered with Fluor as its primary EPC contractor for the Piketon site. Workforce expansion—with 150 net new hires planned across Oak Ridge and Piketon—and the release of certified construction packages demonstrate progress on project milestones. Continuous improvement initiatives target lead time reduction and unit cost optimization from day one.
4. Capital Structure Strength and Funding Strategy
With $2 billion in unrestricted cash and recent capital raises through ATM programs and convertible notes, Centrus is well capitalized to fund its industrial build-out without reliance on expensive capital markets. The company is also exploring additional low-cost capital avenues, including foreign direct investment and national security-related funding, to maintain financial flexibility and support growth.
5. Market Dynamics Favoring Domestic Enrichment
Global LEU supply constraints, accelerated by Russia’s exit from Western markets and increasing electrification demand, create a favorable pricing environment. Centrus’s domestic enrichment capabilities address a critical market gap with a compound annual growth rate in HALEU pricing of 24% from 2019 to 2025. The company’s dual focus on commercial LEU and HALEU for advanced reactors positions it to capitalize on evolving nuclear fuel market dynamics.
Key Considerations
Centrus’s 2025 results and strategic initiatives highlight a company at an inflection point, transitioning from steady-state LEU operations to a capital-intensive growth phase with significant government partnership support. Investors should weigh the following:
- Backlog Conversion Risk: While the LEU backlog is substantial, a portion remains contingent, dependent on capital commitments and contract finalizations.
- Execution Complexity: Manufacturing scale-up, supply chain readiness, and facility construction are complex and require tight project management to meet timelines.
- Contractual and Pricing Visibility: Contract terms and pricing dynamics for SWU and uranium sales influence margin sustainability, especially with ongoing negotiations in the HALEU contract.
- Geopolitical and Regulatory Factors: Continued restrictions on Russian uranium imports and evolving U.S. government policies impact supply-demand balances and market access.
- Capital Deployment Pace: High capital spend guidance ($350 million to $500 million in 2026) reflects aggressive build-out plans but introduces cash flow and execution risk.
Risks
Centrus faces execution risk in delivering on its industrial build-out within projected timelines and costs. Contractual uncertainties, particularly in the HALEU Phase 2 contract, create potential margin volatility. Geopolitical risks, including uranium supply disruptions and regulatory changes, could affect operations and market access. Additionally, the company’s ability to convert contingent backlog and secure additional low-cost capital remains critical to sustaining growth.
Forward Outlook
For 2026, Centrus guided to total revenue between $425 million and $475 million, representing flat year-over-year growth, reflecting some shipment timing uncertainties. Capital deployment is expected to range from $350 million to $500 million, encompassing facility construction, centrifuge manufacturing, and supply chain investments. Operationally, the company plans to finalize critical supplier contracts, add at least 150 net new employees across facilities, and release the first certified construction package for Piketon. Management emphasized ongoing efforts to reduce lead times and unit costs and to provide greater milestone transparency throughout the year.
Takeaways
Centrus Energy’s quarterly and annual disclosures reveal a company strategically positioning itself as a key domestic uranium enrichment supplier amid tightening global supply and rising demand for nuclear fuel. Its substantial LEU backlog and government-backed HALEU award establish a foundation for growth, supported by a strong capital base and operational investments. Execution discipline and contract finalizations will be critical to realizing this potential, with the company’s ability to navigate supply chain complexities and regulatory environments shaping its trajectory.
- Backlog and Funding Anchor Growth: The $2.3 billion LEU backlog and $900 million HALEU award provide revenue visibility and capital to support expansion.
- Execution Focus Drives De-Risking: Supply chain readiness programs, EPC partnerships, and workforce scaling underpin operational milestones.
- Market Positioning Enhances Upside: Centrus’s first-mover advantage in domestic HALEU production and LEU supply amid constrained global markets positions it for long-term growth.
Conclusion
Centrus’s 2025 results and 2026 outlook underscore a pivotal transition from legacy uranium enrichment operations to a growth phase driven by domestic capacity expansion and government collaboration. While execution and contract risks remain, the company’s robust backlog, capital resources, and strategic partnerships offer a compelling foundation for capturing emerging nuclear fuel market opportunities.
Industry Read-Through
Centrus’s progress exemplifies broader industry trends emphasizing domestic nuclear fuel supply chain resilience and the strategic importance of HALEU for advanced reactors. Its government-backed expansion highlights increasing public-private collaboration in energy security. Other uranium enrichment players and nuclear fuel suppliers should monitor Centrus’s execution as a bellwether for U.S. market dynamics and capital allocation priorities. The evolving supply-demand imbalances and geopolitical factors elevating enrichment capacity constraints are likely to influence global nuclear fuel market pricing and investment decisions across the sector.